← ANALYST RATINGS · TIPRANKS
Evotec AG (EVO): analyst forecast and price target
Analyst consensus
Moderate Buy1 Buy0 Hold0 Sell
Ratings of 1 analysts in the last 3 months · top analysts only12-month forecast
Based on 1 price targets given in the last 3 months, the average target is $4.00, the highest $4.00, the lowest $4.00. The average is +189.9% from the last price of $1.38.
| Analyst | Firm | Price target | Rating | Upside | Action | Date | Move vs SPY | |
|---|---|---|---|---|---|---|---|---|
| Swayampakula Ramakanth★★★★★★★★★★#445 · hits 47% · avg +21.2% | H.C. Wainwright | $4.00 | Buy | +189.9% | Reiterated | 14.10.26on TipRanks 06:30 | +7.0%next day −0.6% | ↗ |
| AI xAi Drug Manufacturers - Specialty and GenericxAI Grok-3 | TipRanks - xAI | $1.50 | Sell | +8.7% | Downgrade | 13.10.26on TipRanks 00:05 | — | |
| AI DeepSeek Drug Manufacturers - Specialty and GenericDeepSeek R1-0528 | TipRanks - DeepSeek | $1.50 | Sell | +8.7% | Downgrade | 13.10.26on TipRanks 00:05 | — | |
| AI OpenAI Drug Manufacturers - Specialty and GenericOpenAI 4o | TipRanks - OpenAI | $1.50 | Hold | +8.7% | Reiterated | 13.10.26on TipRanks 00:05 | — | |
| AI Anthropic Drug Manufacturers - Specialty and GenericAnthropic Opus-4.1 | TipRanks - Anthropic | $1.50 | Sell | +8.7% | Reiterated | 13.10.26on TipRanks 00:05 | — | |
| AI Google Drug Manufacturers - Specialty and GenericGemini 2.5Pro | TipRanks - Google | $1.50 | Sell | +8.7% | Reiterated | 13.10.26on TipRanks 00:05 | — | |
| AI PerPlexity Drug Manufacturers - Specialty and GenericPerPlexity SonarPro | TipRanks - PerPlexity | $1.50 | Hold | +8.7% | Reiterated | 13.10.26on TipRanks 00:05 | — | |
| Michael Ryskin★★★★★★★★★★#1994 · hits 58% · avg +5.1% | Bank of America Securities | $3.00 → $2.40−20.0% | Sell | +73.9% | Reiterated | 15.07.26on TipRanks 09:50 | −6.5%next day −1.4% · 5 days −2.0% | ↗ |
| Brendan Smith★★★★★★★★★★#458 · hits 56% · avg +27.3% | TD Cowen | $4.00 → $2.00−50.0% | Hold | +44.9% | Downgrade | 15.07.26on TipRanks Jul 14 19:30 | −6.5%next day −1.4% · 5 days −2.0% | ↗ |
| No ratings for this filter. | ||||||||
Every rating the collector has kept for the last 12 months, including the earlier ones of the same analyst. Latest of each analyst
Best analysts covering Evotec AG
TipRanks picks them by their record on this stock; the figures under the name are their record across all their ratings.
Most accurate
Most profitable
Recommendation trend · top analysts
Strong BuyBuyHoldSell
| Rating | 05.26 | 06.26 | 07.26 | 08.26 | 09.26 | 10.26 |
|---|---|---|---|---|---|---|
| Strong Buy | 4 | 4 | 4 | 3 | 3 | 3 |
| Buy | 2 | 1 | 1 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 0 |
| Sell | 3 | 2 | 2 | 1 | 1 | 0 |
Earnings and sales forecast
Next report: 05.11.26 (Q3 2026, date not confirmed)
Earnings per share
Next quarter’s EPS estimate — $-0.25 (from $-0.39 to $-0.14). Last quarter: $-0.15.
Sales
Next quarter’s sales estimate — $153M (from $147M to $162M). Last quarter: $167M.
Best top-analyst consensus in the sector · Healthcare
About Evotec AG
- CEO: Christian Wojczewski
- Employees: 4,553
- Essener Bogen 7, Hamburg, HA, 22419, DE
- www.evotec.com
Evotec SE operates globally as a dedicated partner, specializing in the discovery and advancement of new pharmaceutical products for the biotechnology and pharmaceutical sectors. Its comprehensive research and development initiatives encompass a broad spectrum of medical areas, such as metabolic disorders (including diabetes and its complications), fibrosis, infectious conditions, central nervous system (CNS) diseases, oncology, pain management, inflammatory ailments, immunological dysfunctions, rare diseases, respiratory conditions, and women's health. The company maintains strategic alliances and collaborations with numerous prominent organizations, including Bayer AG, Lilly, Chinook Therapeutics, Novo Nordisk A/S, Galapagos, Pfizer Inc., CONBA Pharmaceutical Co., Ltd., Bristol Myers Squibb Company, Zhejiang JingXin Pharmaceutical Co., Ltd, Kazia Therapeutics, Apeiron Biologics, and Takeda Pharmaceuticals. Established in 1993, the company was formerly known as Evotec AG, changing its name to Evotec SE in April 2019. Its corporate headquarters are located in Hamburg, Germany.
Data from the stock’s TipRanks forecast page, read 60 min ago. It is read again as soon as a new rating appears and at least every 8 hours. TipRanks ↗